Supplement
Meeting Spotlight: 62nd American Society of Hematology Annual Meeting & Exposition
-2020Focus on CAR T-cell therapies from the 62nd American Society of Hematology Annual Meeting & Exposition held December 5-8, 2020.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves T-DXd Plus Pertuzumab for HER2-Positive Breast Cancer
2
Teclistamab/Daratumumab Earns FDA Priority Voucher for R/R Myeloma
3
Roxadustat Granted Orphan Drug Designation for Myelodysplastic Syndromes
4
FDA Fast-Tracks Muzastotug Combo in MSS Metastatic Colorectal Cancer
5
